Physically simulating human organs on computer chips in a lab setting and studying their reactions to drugs and other stimuli could be the future of medical research.
Imagine using stem cells to rebuild the heart following severe heart failure or coronary heart disease. James T. Willerson, MD, President and Medical Director of the Texas Heart Institute at St. Luke’s…
James T. Willerson, MD, President and Medical Director of the Texas Heart Institute at St. Luke’s Episcopal Hospital, addresses a topic of great concern in cardiology today: leakage following aortic…
James T. Willerson, MD, President and Medical Director of the Texas Heart Institute at St. Luke’s Episcopal Hospital, discusses groundbreaking new therapies to cure cardiovascular disease using stem cell technology.…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy not only reduces the risk of a first heart failure event but also recurring events, according to an analysis of…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation on amiodarone, the incidence of thyroid dysfunction is identical in those taking the brand-name formulation of the drug…
NEW YORK (Reuters Health) – A new population-based study finds the incidence of pulmonary complications associated with amiodarone to be relatively low, but still 50% higher among patients…
NEW YORK (Reuters Health) – A Danish observational study provides no evidence that use of angiotensin receptor blockers (ARBs) is associated with an increased risk of incident cancer…
NEW YORK (Reuters Health) – Atrial flutter seen in patients in the emergency department (ED) resolves more often with electrical cardioversion than with antiarrhythmic drug treatment, and long-term…
